Lupin, Jubilant launch Diovan copy as Ranbaxy exclusivity ends – dnaindia.com
0After Ranbaxy, three more domestic (Indian) pharmaceutical companies – Lupin, Aurobindo Pharma and Jubilant Life Sciences – have received final approval from the US drug regulator to sell generic valsartan in the US market.
The drug is used to treat hypertension and to lower blood pressure.
Read more – dnaindia.com